# A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)

> **NCT07685236** · — · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 586 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer (CRC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07685236
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-29
- **Primary completion:** 2027-06-28
- **Final completion:** 2027-06-28
- **Target enrollment:** 586 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685236, "A Biomarker Exploration Study for Predicting Localization of Recurrence and Metastasis in Colorectal Cancer (PROBE Study)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*